Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine - Sorbonne Université Access content directly
Journal Articles Translational Psychiatry Year : 2018

Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine

Kim Fejgin
  • Function : Author
Vibeke Nielsen
  • Function : Author
Jacob Nielsen
  • Function : Author
  • PersonId : 870443
Michael Didriksen
  • Function : Author

Abstract

The 22q11.2 deletion syndrome (22q11.2DS) confers high risk of neurodevelopmental disorders such as schizophrenia and attention-deficit hyperactivity disorder. These disorders are associated with attentional impairment, the remediation of which is important for successful therapeutic intervention. We assessed a 22q11.2DS mouse model (Df(h22q11)/+) on a touchscreen rodent continuous performance test (rCPT) of attention and executive function that is analogous to human CPT procedures. Relative to wild-type littermates, Df(h22q11)/+ male mice showed impaired attentional performance as shown by decreased correct response ratio (hit rate) and a reduced ability to discriminate target stimuli from non-target stimuli (discrimination sensitivity, or d’). The Df(h22q11)/+ model exhibited decreased prefrontal cortical-hippocampal oscillatory synchrony within multiple frequency ranges during quiet wakefulness, which may represent a biomarker of cognitive dysfunction. The stimulant amphetamine (0–1.0 mg/kg, i.p.) dose-dependently improved d’ in Df(h22q11)/+ mice whereas the highest dose of modafinil (40 mg/kg, i.p.) exacerbated their d’ impairment. This is the first report to directly implicate attentional impairment in a 22q11.2DS mouse model, mirroring a key endophenotype of the human disorder. The capacity of the rCPT to detect performance impairments in the 22q11.2DS mouse model, and improvement following psychostimulant-treatment, highlights the utility and translational potential of the Df(h22q11)/+ model and this automated behavioral procedure.
Fichier principal
Vignette du fichier
s41398-018-0295-3.pdf (1.64 Mo) Télécharger le fichier
Origin Publication funded by an institution
Loading...

Dates and versions

hal-01924805 , version 1 (16-11-2018)

Identifiers

Cite

Simon R O Nilsson, Christopher J Heath, Samir Takillah, Steve Didienne, Kim Fejgin, et al.. Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamine. Translational Psychiatry, 2018, 8 (1), pp.247. ⟨10.1038/s41398-018-0295-3⟩. ⟨hal-01924805⟩
158 View
117 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More